Abstract 3: Patient Satisfaction and Healthcare Service Utilization Following Premature Acute Coronary Syndrome

Author(s):  
Marisa Okano ◽  
Roxanne Pelletier ◽  
Hassan Behlouli ◽  
Louise Pilote ◽  

Objectives. Patient centered care is recognized as central to a high-quality healthcare system. Satisfaction with healthcare services may be differentially experienced among young adults suffering from heart disease. The current study examined the association between patient satisfaction with healthcare services, utilization, and clinical outcomes in patients with premature acute coronary syndrome (ACS). Methods and Results. We used data from 1033 patients (≤ 55 years) hospitalized for ACS and enrolled into the prospective cohort study, GENESIS-PRAXY (GENdEr and Sex determInantS of cardiovascular disease: from bench to beyond PRemature Acute Coronary SYndrome). Participants were recruited between January 2009-April 2013, from 24 centers across Canada, 1 in the US, and 1 in Switzerland. Patient satisfaction with treatment and subsequent healthcare service utilization/clinical outcomes were assessed within 12 months post-index ACS through questionnaire and medical chart review. The median age of our cohort was 48 years and 30% were female. Ninety two percent of males and females reported high satisfaction with healthcare services; however, among patients with low satisfaction we observed lower social support (48% vs. 24%; p<.0001) and higher rates of depression (46% vs. 22%; p<.0001) at baseline. Multivariable Cox regressions adjusted for patient characteristics and clinical risk factors indicated lower risk of cardiac ER visits (HR=0.56; 95%CI, 0.34-0.93; P=0.01) and cardiac rehospitalization (HR=0.55; 95%CI, 0.28-1.07; P=0.08) among patients with higher satisfaction. There was no association between patient satisfaction level and risk of major adverse cardiac events (MACE) (HR=0.61; 95% CI, 0.32-1.19 P=0.15). Conclusions. Patients with lower satisfaction with healthcare services at index ACS were more likely to visit the ER and to be rehospitalized for cardiac reasons. Patient satisfaction level was not associated with risk of adverse clinical outcomes. Our results suggest that the younger ACS population may be a tangible target for reducing healthcare utilization through increased patient satisfaction.

Author(s):  
Moritz von Scheidt ◽  
Dario Bongiovanni ◽  
Ulrich Tebbe ◽  
Bernd Nowak ◽  
Jan Stritzke ◽  
...  

Abstract OBJECTIVES The optimal antiplatelet strategy in patients undergoing CABG remains unclear. This is the first meta-analysis investigating the clinical outcomes associated with ticagrelor-based antiplatelet regimens in patients receiving CABG. METHODS Relevant scientific databases were searched for studies investigating antiplatelet regimens after CABG from inception until April 1, 2019. Studies which randomly assigned CABG patients to either ticagrelor-based or control antiplatelet regimens were eligible. The primary outcome of this analysis was all-cause death. The main secondary outcome was MI. Other outcomes of interest were cardiac death, major adverse cardiac events, stroke and bleeding. This study is registered with PROSPERO, number CRD42019122192. RESULTS Five trials comprising 3996 patients (2002 assigned to ticagrelor-based and 1994 to control antiplatelet regimens) were eligible for quantitative synthesis. The median follow-up was 12 months. Control antiplatelet regimens consisted of either aspirin or clopidogrel or both. As compared to control, ticagrelor-based regimens reduced the risk of all-cause death [0.61 (0.43–0.87); P = 0.007], cardiac death [0.58 (0.39–0.86); P = 0.007] and major adverse cardiac events [0.79 (0.63–0.98); P = 0.03], without difference in the risk of MI [0.76 (0.50–1.18); P = 0.22], stroke [0.99 (0.56–1.78); P = 0.98] or bleeding [1.04 (0.95–1.14); P = 0.41]. There was a treatment effect modification for the primary outcome associated with trials enrolling predominantly patients with acute coronary syndrome (P for interaction = 0.038). CONCLUSIONS In patients receiving CABG, ticagrelor-based regimens reduce mortality and major adverse cardiac events without excess bleeding risk as compared with aspirin monotherapy or the combination of aspirin and clopidogrel. The benefit of ticagrelor-based regimens is more relevant in those studies enrolling predominantly patients with acute coronary syndrome. These findings require further confirmation in randomized trials focused on this subset of patients and powered for clinical outcomes.


Choonpa Igaku ◽  
2010 ◽  
Vol 37 (5) ◽  
pp. 577-585
Author(s):  
Hideaki MATSUURA ◽  
Akira YAMADA ◽  
Kunihiko SUGIMOTO ◽  
Yoshimi OHIRA ◽  
Ayako TAKAHASHI ◽  
...  

2020 ◽  
Vol 72 ◽  
pp. S5
Author(s):  
Shahood Ajaz Kakroo ◽  
Kala Jeethender Kumar ◽  
O. Sai Satish ◽  
M. Jyotsna ◽  
B. Srinivas ◽  
...  

2021 ◽  
Vol 8 (2) ◽  
pp. 205510292110291
Author(s):  
Drexler James

This study ( N = 780) examines the indirect effects of hardiness—health locus of control (HLOC), health competence (HC), health value (HV)—on past-year healthcare provider visit via attitudes toward seeking and receiving professional healthcare services (ATSRPHS). Across four health domains (dental, general health, mental, vision), ATSRPHS mediated the indirect effect of (1) HV and (2) internal HLoC on past-year healthcare provider visit. ATSRPHS also mediated the indirect effect of external HLoC on past-year visit to healthcare provider visit for general medical, mental, and vision health. ATSRPHS did not mediate any indirect effect of HC on past-year healthcare provider visit. This research contributes to understanding determinants of healthcare service utilization among Black American adults.


Sign in / Sign up

Export Citation Format

Share Document